Forensic · SNOA
Sonoma Pharmaceuticals
Top signals
Atm Offering Active
424B5 ATM offering prospectus in the last 6 months (active dilution).
+12
Bear case preview · free
Sonoma Pharmaceuticals triggered a moderate red flag primarily due to an active ATM offering, which represents ongoing shareholder dilution through continuous equity issuance rather than a one-time capital raise. This mechanism allows the company to sell shares opportunistically at market prices, effectively transferring value from existing shareholders to the company's balance sheet—a pattern typically associated with companies facing cash constraints or valuation uncertainty. Watch for the pace of ATM utilization in the next 30-90 days, particularly whether the offering accelerates or whether management provides guidance on capital deployment, as aggressive dilution combined with limited cash burn visibility would signal heightened financial stress.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
1 S-3 + 424B5 filing
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on SNOA
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on SNOA + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.